Related Experiment Video
Updated: May 22, 2026
06:43
Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
Published on: March 29, 2017
Brain-Spleen Inflammatory Coupling: A Literature Review
The Einstein Journal of Biology and Medicine : EJBM
|May 22, 2012
Summary
Brain injury triggers spleen inflammation via brain-spleen inflammatory coupling. Stimulating the alpha7 nicotinic acetylcholine receptor (α7NAchR) on splenic macrophages reduces this inflammation, improving outcomes in neurological conditions.
Area of Science:
- Neuroimmunology
- Autonomic Nervous System
- Inflammation Research
Background:
- Traumatic brain injury (TBI) is linked to autonomic pro-inflammatory cytokine release from splenic macrophages.
- This brain-spleen inflammatory coupling is a key area of interest for TBI treatment development.
- Neuroinflammation exacerbates neurological damage in various conditions.
Purpose of the Study:
- To investigate the role of splenic macrophages in TBI-induced neuroinflammation.
- To explore the potential of modulating splenic inflammation via the autonomic nervous system for therapeutic benefit.
- To examine the efficacy of cholinergic stimulation of splenic macrophages in preclinical models.
Main Methods:
- Investigated the brain-spleen inflammatory coupling mechanism.
- Utilized animal models of sepsis, stroke, and TBI.
- Focused on cholinergic stimulation of the alpha7-subunit nicotinic acetylcholine receptor (α7NAchR) on splenic macrophages.
Main Results:
- Cholinergic stimulation of α7NAchR on splenic macrophages inhibits pro-inflammatory cytokine release.
- This parasympathetic nervous system-mediated inhibition improves outcomes in animal models of sepsis, stroke, and TBI.
- Evidence supports a beneficial role for splenic inhibition in neurological conditions.
Conclusions:
- Modulating splenic inflammation through the autonomic nervous system presents a promising therapeutic strategy.
- Targeting brain-spleen inflammatory coupling offers potential for treating TBI and other neuroinflammatory diseases.
- Further research into splenic inhibition could lead to novel treatments for conditions involving neuroinflammation.
More Related Videos
Related Concept Videos
01:28Inflammation: Introduction
Inflammation is a fundamental, protective biological response of vascularized tissues to cellular injury, infection, or harmful stimuli. Its primary function is to eliminate the initial cause of injury, clear necrotic cells and damaged tissue, and initiate the necessary repair processes.Cardinal SignsAcute inflammation presents with classic signs. Redness results from vasodilation and increased blood flow. Heat is due to increased metabolism and circulation. Swelling results from the...
01:25Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:26Acute Inflammation I: Inflammatory Response
Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
01:30Inflammatory Response I: Vascular and Cellular
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...